ArticleTherapeutic advances in hematology2022

Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10

Paola Guglielmelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.